EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice

Kyung Eun Kim, Jaewoong Lee, Hyun Joo Shin, Eun Ae Jeong, Hye Min Jang, Yu Jeong Ahn, Hyeong Seok An, Jong Youl Lee, Meong Cheol Shin, Soo Kyoung Kim, Won Gi Yoo, Won Ho Kim und 1 weitere

Hepatology · 2023-03 · 77 (3) · 888-901

DOI: 10.1002/hep.32569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatology, online erschienen am 17.02.2023. Verfasst von Kyung Eun Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Convergence Medical Science , College of Medicine , Institute of Health Sciences , Gyeongsang National University , Jinju ,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: In obesity and type 2 diabetes mellitus, leptin promotes insulin resistance and contributes to the progression of NASH via activation of hepatic stellate cells (HSCs). However, the pathogenic mechanisms that trigger HSC activation in leptin‐deficient obesity are still unknown. This study aimed to determine how HSC‐targeting lipocalin‐2 (LCN2) mediates the transition from simple steatosis to NASH. Approach and Results: Male wild‐type (WT) and ob/ob mice were fed a high‐fat diet (HFD) for 20 weeks to establish an animal model of NASH with fibrosis. Ob/ob mice were subject to caloric restriction or recombinant leptin treatment. Double knockout (DKO) mice lacking both leptin and lcn2 were also fed an HFD for 20 weeks. In addition, HFD‐fed ob/ob mice were treated with gadolinium trichloride to deplete Kupffer cells. The LX‐2 human HSCs and primary HSCs from ob/ob mice were used to investigate the effects of LCN2 on HSC activation. Serum and hepatic LCN2 expression levels were prominently increased in HFD‐fed ob/ob mice compared with normal diet‐fed ob/ob mice or HFD‐fed WT mice, and these changes were closely linked to liver fibrosis and increased hepatic α‐SMA/matrix metalloproteinase 9 (MMP9)/signal transducer and activator of transcription 3 (STAT3) protein levels. HFD‐fed DKO mice showed a marked reduction of α‐SMA protein compared with HFD‐fed ob/ob mice. In particular, the colocalization of LCN2 and α‐SMA was increased in HSCs from HFD‐fed ob/ob mice. In primary HSCs from ob/ob mice, exogenous LCN2 treatment induced HSC activation and MMP9 secretion. By contrast, LCN2 receptor 24p3R deficiency or a STAT3 inhibitor reduced the activation and migration of primary HSCs. Conclusions: LCN2 acts as a key mediator of HSC activation in leptin‐deficient obesity via α‐SMA/MMP9/STAT3 signaling, thereby exacerbating NASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseAnimalsHumansMaleMiceDiet, High-FatHepatic Stellate CellsLeptinLipocalin-2LiverMatrix Metalloproteinase 9Mice, Inbred C57BLMice, Inbred StrainsMice, KnockoutObesity

Substanzen

LeptinLipocalin-2Matrix Metalloproteinase 9

Autor:innen und Institutionen

  • Department of Anatomy and Convergence Medical Science , College of Medicine , Institute of Health Sciences , Gyeongsang National University , Jinju , Republic of Korea.
  • College of Pharmacy , Research Institute of Pharmaceutical Sciences , Gyeongsang National University , Jinju , Republic of Korea.
  • Department of Internal Medicine , College of Medicine , Institute of Health Sciences , Gyeongsang National University , Jinju , Republic of Korea.
  • Department of Parasitology and Tropical Medicine , College of Medicine , Institute of Health Sciences , Gyeongsang National University , Jinju , Republic of Korea.
  • Division of Cardiovascular Diseases , Center for Biomedical Sciences , Korea National Institute of Health , Cheongju , Republic of Korea.

Zitieren

APA

Kim, K. E., Lee, J., Shin, H. J., Jeong, E. A., Jang, H. M., Ahn, Y. J., An, H. S., Lee, J. Y., Shin, M. C., Kim, S. K., Yoo, W. G., Kim, W. H., & Roh, G. S. (2023). Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice. Hepatology, 77(3), 888-901. https://doi.org/10.1002/hep.32569

Vancouver

Kim KE, Lee J, Shin HJ, Jeong EA, Jang HM, Ahn YJ, et al. Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice. Hepatology. 2023;77(3):888-901. doi:10.1002/hep.32569

BibTeX
@article{Kim2023,
  author = {Kim, Kyung Eun and Lee, Jaewoong and Shin, Hyun Joo and Jeong, Eun Ae and Jang, Hye Min and Ahn, Yu Jeong and An, Hyeong Seok and Lee, Jong Youl and Shin, Meong Cheol and Kim, Soo Kyoung and Yoo, Won Gi and Kim, Won Ho and Roh, Gu Seob},
  title = {Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice},
  journal = {Hepatology},
  year = {2023},
  volume = {77},
  number = {3},
  pages = {888--901},
  doi = {10.1002/hep.32569}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche